TLX Telix Pharmaceuticals Limited

$8.77

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company is headquartered in North Melbourne, Australia.

Website: https://telixpharma.com

Sector
TECHNOLOGY
Industry
GENERAL
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
2007191
Address
NONE
Valuation
Market Cap
$5.23B
P/E Ratio
173.44
PEG Ratio
nan
Price to Book
20.71
Performance
EPS
$0.09
Dividend Yield
—
Profit Margin
7.62%
ROE
20.50%
Technicals
50D MA
$15.60
200D MA
$15.60
52W High
$30.36
52W Low
$13.61
Fundamentals
Shares Outstanding
335M
Target Price
$20.19
Beta
2.38

TLX EPS Estimates vs Actual

● Estimated
● Actual

TLX News & Sentiment

Nov 21, 2025 • Benzinga NEUTRAL
DEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions - Stride ( NYSE:LRN ) , Six Flags Entertainment ( NYSE:FUN )
BENSALEM, Pa., Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Nov 21, 2025 • Benzinga NEUTRAL
DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Inspire Medical Systems ( NYSE:INSP ) , Six Flags Entertainment ( NYSE:FUN )
LOS ANGELES, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Nov 20, 2025 • Benzinga NEUTRAL
Bragar Eagel & Squire, P.C. Reminds Investors of Telix, Freeport, and Primo Brands to Contact the Firm About their Rights Before Lead Plaintiff Deadlines - Primo Brands ( NYSE:PRMB ) , Freeport-McMoRan ( NYSE:FCX )
NEW YORK, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telix Pharmaceuticals Limited ( NASDAQ:TLX ) , Freeport-McMoran Inc. ( NYSE:FCX ) ...
Nov 20, 2025 • Benzinga NEUTRAL
Telix Pharmaceuticals Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX - Telix Pharmaceuticals ( NASDAQ:TLX )
NEW YORK, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. ( "Telix Pharmaceuticals Ltd." or the "Company" ) ( NASDAQ:TLX ) of a class action securities lawsuit.
Nov 20, 2025 • Benzinga NEUTRAL
Deadline Alert: Telix Pharmaceuticals Limited ( TLX ) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - Telix Pharmaceuticals ( NASDAQ:TLX )
LOS ANGELES, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Limited ( "Telix" or ...
Nov 20, 2025 • Benzinga NEUTRAL
TLX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals - Telix Pharmaceuticals ( NASDAQ:TLX )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options
Sentiment Snapshot

Average Sentiment Score:

-0.030
50 articles with scored sentiment

Overall Sentiment:

Neutral

TLX Reported Earnings

Aug 20, 2025
Jun 30, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.01
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Apr 22, 2025
Mar 31, 2025 (Pre market)
0.09 Surprise
  • Reported EPS: $0.09
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Feb 20, 2025
Dec 31, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $0.06
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Oct 17, 2024
Sep 30, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%

Financials